Vallejo-Vaz, A J, Stevens, C A T, Lyons, A R M, Dharmayat, K I, Freiberger, T, Hovingh, G K, Mata, P, Raal, F J, Santos, R D, Soran, H, Watts, G F, Abifadel, M, Aguilar-Salinas, C A, Alhabib, K F, Alkhnifsawi, M, Almahmeed, W, Alnouri, F, Alonso, R, Al-Rasadi, K, Al-Sarraf, A, Al-Sayed, N, Araujo, F, Ashavaid, T F, Banach, M, Béliard, S, Benn, M, Binder, C J, Bogsrud, M P, Bourbon, M, Chlebus, K, Corral, P, Davletov, K, Descamps, O S, Durst, R, Ezhov, M, Gaita, D, Genest, J, Groselj, U, Harada-Shiba, M, Holven, K B, Kayikcioglu, M, Khovidhunkit, W, Lalic, K, Latkovskis, G, Laufs, U, Liberopoulos, E, Lima-Martinez, M M, Nordestgaard, B G, Tybjærg-Hansen, A, Chen, Y & EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 2021, ' Global perspective of familial hypercholesterolaemia : a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) ', The Lancet, vol. 398, no. 10312, pp. 1713-1725 . https://doi.org/10.1016/S0140-6736(21)01122-3
Lancet, 393(10184), 1937-1947. Elsevier Limited The Lancet, 393(10184), 1937-1947. Elsevier Lancet, Vol. 393, no. 10184, p. 1937-1947 (2019) LANCET, 393(10184), 1937-1947. ELSEVIER SCIENCE INC Heerspink, H J L, Parving, H-H, Andress, D L, Bakris, G, Correa-Rotter, R, Hou, F-F, Kitzman, D W, Kohan, D E, Makino, H, McMurray, J J V, Melnick, J Z, Miller, M G, Pergola, P E, Perkovic, V, Tobe, S W, Yi, T, Wigderson, M, de Zeeuw, D & Webb, D J 2019, ' Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial ', The Lancet, vol. 393, no. 10184 . https://doi.org/10.1016/S0140-6736(19)30772-X Heerspink, H J L, Parving, H-H, Andress, D L, Bakris, G, Correa-Rotter, R, Hou, F-F, Kitzman, D W, Kohan, D, Makino, H, McMurray, J J V, Melnick, J Z, Miller, M G, Pergola, P E, Perkovic, V, Tobe, S, Yi, T, Wigderson, M, de Zeeuw, D & SONAR Committees and Investigators 2019, ' Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR) : a double-blind, randomised, placebo-controlled trial ', The Lancet, vol. 393, no. 10184, pp. 1937-1947 . https://doi.org/10.1016/S0140-6736(19)30772-X